FREE follow-up consultations with our preferred prescriber
FREE follow-up consultations with our preferred prescriber

Evidence · Education · Clinical reasoning

Medicinal Cannabis Education for Doctors

Explore clinician learning resources covering formulation philosophy, the endocannabinoid system, treatment planning and product formats. Start with the scientific framework, then continue to the relevant clinical resources. Product-specific materials require verified clinician access on the live website.

Prescribing, access and Australian market resources

How to Prescribe Medicinal Cannabis in Australia

A practical overview for Australian doctors covering assessment, SAS-B and Authorised Prescriber pathways, product categories, consent and follow-up.

Read resource

Medicinal Cannabis Market Growth in Australia: Reading the Data

Understand Australian medicinal cannabis growth figures, the difference between approvals and patients, and how to interpret SAS and AP data.

Read resource

Medicinal Cannabis in Australia: Access and Product Formats

Explore Australian medicinal cannabis access, oral and inhaled product formats, clinical selection factors and the limits of market statistics.

Read resource

Medicinal Cannabis Prescriber Training: Learning Structure

Explore a proposed foundation and advanced learning structure covering pharmacology, patient selection, access pathways, safety and clinical governance.

Read resource

Paediatric Medicinal Cannabis Access in Australia

Understand Australian paediatric medicinal cannabis access, specialist involvement, evidence boundaries, consent and monitoring considerations.

Read resource

Scientific framework and formulation philosophy

Multi-Pathway Formulation Architecture

Explore a five-layer formulation model: cannabinoids, targeted ingredients, terpenes, recovery components and delivery. Read the evidence limits.

Read resource

Multi-System Drivers and Formulation Philosophy

Understand how sleep, pain, stress and interacting body systems inform a multi-pathway formulation model, with practical questions for clinical review.

Read resource

Multi-Pathway Cannabinoid Therapy: Clinical Framework

Read a clinician-focused framework covering presentation, route, cannabinoid exposure, adjunct evidence, interactions and outcome monitoring.

Read resource

Multi-Pathway Treatment Rationale

Explore the scientific rationale for considering cannabinoid therapy within wider neurological, immune, metabolic and behavioural care.

Read resource

Clinician library: protocols and product resources

Prescriber Training: Understanding the Treatment Framework

Understand foundation, daytime, night and breakthrough treatment roles, with assessment, monitoring and review principles for prescribers.

Read resource

BASE, FLOW and RESET: Clinical Rationale

Understand the intended foundation, daytime and night treatment roles behind BASE, FLOW and RESET in a structured clinical framework.

Read resource

Oral Medicinal Cannabis: Oils and Gummies Dossier

Clinician resource covering oral formulation design, cannabinoid concentrations, supporting ingredients, dose interpretation and review.

Read resource

Inhaled Medicinal Cannabis: Clinician Protocol

Clinician resource on inhaled formats, prior THC exposure, patient selection, impairment, adverse effects and treatment review.

Read resource

Medicinal Cannabis Oils: Clinical Product Guide

Clinician reference on medicinal cannabis oils, formulation differences, product specifications and clinical assessment considerations.

Read resource

Medicinal Cannabis Gummies: Clinical Product Guide

Clinician reference on medicinal cannabis gummies, formulation differences, product specifications and clinical assessment considerations.

Read resource

Medicinal Cannabis Flower: Clinical Product Guide

Clinician reference on medicinal cannabis flower, formulation differences, product specifications and clinical assessment considerations.

Read resource

Medicinal Cannabis Vapes: Clinical Product Guide

Clinician reference on medicinal cannabis vapes, formulation differences, product specifications and clinical assessment considerations.

Read resource